Press releases - conect4children

2020

29 September 2020

First site open for patient recruitment into KD-CAAP Study

2019

29 April 2019

New conect4children Consortium Selects Inaugural Research Portfolio to Advance Development of Innovative Paediatric Medicines

2018

18 May 2018

Launch of a new public-private partnership to improve clinical trial infrastructure to facilitate the development of new drugs for children in Europe

conect4childrenFollow

conect4children @c4c_network·

24 Nov

We are pleased to announce that 3 #patients have been already included in the #TREOCAPA study sponsorized by @Inserm at @CHUnantes

Prophylactic TREatment Of the duCtus Arteriosus in
Preterm infants by Acetaminophen

2 patients - Phase II 👶👶
1 patient - Phase III🧑‍🍼

@IMI_JU

Reply on Twitter 1331156516733394946 Retweet on Twitter 13311565167333949463 Like on Twitter 133115651673339494614 Twitter 1331156516733394946

Retweet on Twitter conect4children Retweeted

EU Medicines Agency@EMA_News·

23 Nov

There are over 6,000 #RareDiseases that affect about 30 million people in the 🇪🇺. On Monday, 30 Nov, EMA is organising a workshop on regulatory support for development of #OrphanMedicines:
👉https://www.ema.europa.eu/en/news/workshop-regulatory-support-development-orphan-medicines

Reply on Twitter 1330891251172913154 Retweet on Twitter 133089125117291315421 Like on Twitter 133089125117291315432 Twitter 1330891251172913154

Retweet on Twitter conect4children Retweeted

KD-CAAP @KdCaap·

22 Nov

We L❤️VE tiny hearts!

#Kawasaki_Disease = #1 cause acquired ❤️ disease in children! Delays in Dx mean, even with treatment 19% UK children overall & c.40% infants= 💔damage

KDCAAP trial is designed to evaluate additional #steroid therapy! @c4c_network

DM us to find out more!

Reply on Twitter 1330534378326405121 Retweet on Twitter 13305343783264051215 Like on Twitter 13305343783264051217 Twitter 1330534378326405121